SavedAdd your journal

Journals / The Journal of Breast Health / 2016 / Cilt: 12 - Sayı: 1

Metaplastic Breast Cancer

Halil TÜRKAN
M. Şehsuvar GÖKGÖZ
N. Serhat PARLAK
Pages
47–49
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein, we aimed to present a 74-year-old patient with metaplastic breast cancer along with clinical, radiologic and pathologic properties.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Metaplastic Breast Cancer (MBC) is a term referring to a heterogeneous group with malignant epithelial and mesenchymal tissue components.
📊
Key Findings & Data:MBC is a rare disease, accounting for 0.2% of all breast cancers.
💡
Conclusion & Impact:Herein, we aimed to present a 74-year-old patient with metaplastic breast cancer along with clinical, radiologic and pathologic properties.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Metaplastic Breast Cancer (MBC) is a term referring to a heterogeneous group with malignant epithelial and mesenchymal tissue components. MBC is a rare disease, accounting for 0.2% of all breast cancers. Most MBC are triple negative cancers with poor prognosis and an aggressive clinical course. Herein, we aimed to present a 74-year-old patient with metaplastic breast cancer along with clinical, radiologic and pathologic properties.

🔖

Cite This Article

TÜRKAN, H., GÖKGÖZ, M. Ş., PARLAK, N. S. (2016). Metaplastic Breast Cancer. The Journal of Breast Health, Cilt: 12 - Sayı: 1, 47–49. https://ajindex.com/articles/362667

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Huvos AG, Lucas JC, Foote FW. Metaplastic breast carcinoma: Rare form of mammary cancer. NY State J Med 1973; 73:1078-1082. (PMID: 4348806
  2. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast I: Matrix-producing carcinoma. Human Pathol 1989; 20:628-635. (PMID: 2544506) [CrossRef] 3. Luini A, Aguilar M, Gatti G, Fasani R, Botteri E, Brito JA, Maisonneuve P, Vento AR, Viale G. Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the european Institute of Oncology and review of the literature. Breast Cancer Res Treat 2007; 101:349-353. (PMID: 17009109) [CrossRef] 4. Oberman HA. Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients. Am J Surg Pathol 1987; 11:918-929. (PMID: 2825549) [CrossRef] 5. Rosen PP (Ed). Rosen’s breast pathology. Philadelphia; Lippincott Williams&Wilkins, 2001: p. 425-453
  3. Carter MR, Hornick JL, Lester S, Fletcher CD. Spindlecell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases. Am J Surg Pathol 2006; 30:300-309. (PMID: 16538049
  4. Karaman N, Yılmaz KB, Kebat T, Hüseyinova S, Özaslan C. 16 yaşında bir bayan hastada memenin metaplastik karsinomu. J Breast Health 2007; 1:35-37
  5. Günhan-Bilgen I, Memis A, Üstün EE, Zekioglu O, Özdemir N. Metaplastic carcinoma of the breast: clinical, mammographic, and sonographic finding swith histopathologic correlation. AJR 2002; 178:1421-1425. [CrossRef] 9. Al Sayed AD, El Weshi AN, Tulbah AM, Rahal MM, Ezzat AA. Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors. Acta Oncol 2006; 45:188-195. (PMID: 16546865) [CrossRef] 10. Hennessy BT, Giordano S, Broglio K, Duan Z, Trent J, Buchholz TA, Babiera G, Hortobagyi GN, Valero V. Biphasic metaplasti csarcomatoid carcinoma of the breast. Ann Oncol 2006; 17:605-613. (PMID: 16469754) [CrossRef] 11. Sitterding SM, Wiseman WR, Schiller CL, Luan C, Chen F, Moyano JV, Watkin WG, Wiley EL, Cryns VL, Diaz LK. AlphaB-crystallin: A novel marker of invasiv basal-like and metaplastic breast carcinomas. Ann Diagn Pathol 2008; 12:33-40. (PMID: 18164413) [CrossRef] 12. Rayson D, Adjei AA, Suman VJ, Wold LE, Ingle JN. Metaplastic breast cancer: prognosis and responseto systemic therapy. Ann Oncol 1999; 10:413-419. (PMID: 10370783) [CrossRef] 13. Buzdar AU, Valero V, Theriault RL. Pathological complete response to chemotherapy is related to hormone receptor status. San Antonio Breast Cance